President-elect Donald Trump campaigned in 2024 on a chaotic platform that included promises to roll back access to gender-affirming care for transgender individuals.
As with many of Trump’s proposed plans, exact details of what this would entail are difficult to track. However, banning gender-affirming care at the federal level, which would involve a halt on federal funding for any procedures and possible legal action against existing providers, would likely result in a decrease in access to this kind of care across the country. Trump has especially focused on banning any kind of gender-affirming care for transgender youth.
Gender-affirming care includes a wide variety of treatments including hormone therapies and several different kinds of surgeries. Most often, these treatments are accessed by transgender individuals. However, a total ban on such therapies will also impact other patients. Young people may be prescribed hormone therapies to treat precocious puberty, acne vulgaris and menstrual pain. In adults, hormone therapies are used for menopausal symptoms in women and can also be used to treat fertility problems.
Due to the very small percentage of the American population that requires gender-affirming care, it is unlikely that any major markets tracked by GlobalData will be affected by these new policies. However, with the ambiguousness of Trump’s current plans, it is difficult to determine if a ban on gender-affirming care at the federal level will spill over into other areas.
The lack of support for this kind of care could cause a significant decrease in innovation for medical devices within the space in the US, as a blanket ban on these procedures would make it legally risky for companies to try to market new medical devices.
It remains to be seen what the second Trump administration will do to limit gender-affirming care. A federal ban will likely be challenged in courts by Democratic states, which would allow for this care to continue in certain areas of the country. Without knowing more about the Trump administration’s proposed plans, it remains difficult to predict what effect this will have on the medical device market.
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
[View profiles in store](https://www.globaldata.com/companies/?utm_source=Analyst Comment&utm_term=visit_company_profile&utm_content=Gender-affirming care in US under threat from new Trump policies)
Company Profile – free sample
Your download email will arrive shortly
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData